Journey Medical Corporation (DERM) vs Siga Technologies Inc. (SIGA)

Journey Medical Corporation and Siga Technologies Inc. are both Drug Manufacturers Specialty & Generic companies. Siga Technologies Inc. is the larger, with a market value of $213.4M against $121.4M — 1.8× the size. Journey Medical Corporation grew revenue faster over the last twelve months: 20.9% against −70.1%. Siga Technologies Inc. has the higher net margin (−5.19% vs −8.95%) and the lower return on invested capital (−14.6% vs −5.89%). Across the 19 metrics below, Journey Medical Corporation leads on 10 and Siga Technologies Inc. on 9.

Valuation

Metric DERM SIGA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 1.73 3.97 2.08
P/B 3.68 1.29 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA 67.73 n/m 12.22
EV/Sales 1.73 4.74 2.87
Earnings yield (5.12%) (1.35%) (15.94%)
Free cash flow yield (19.02%) (9.63%) 0.00%

Profitability

Metric DERM SIGA Drug Manufacturers Specialty & Generic median
Gross margin 65.45% 54.35% 53.51%
Operating margin (4.41%) (20.76%) 0.00%
Net margin (8.95%) (5.19%) (2.45%)
Free cash flow margin (10.99%) (37.58%) 0.00%
Return on equity (23.77%) (1.49%) (0.80%)
Return on assets (6.80%) (1.36%) (1.67%)
Return on invested capital (5.89%) (14.59%) 0.00%

Growth

Metric DERM SIGA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 20.89% (70.13%) 5.22%
EPS growth (last fiscal year) 34.72% (60.98%) 42.91%
Revenue growth, 5-year CAGR 6.79% (5.42%) 7.24%
Net income growth, 5-year CAGR 0.00% (16.20%) 0.00%

Health

Metric DERM SIGA Drug Manufacturers Specialty & Generic median
Debt to equity 0.79 0.00 0.04
Current ratio 1.59 21.72 2.41
Net debt to EBITDA (0.35) (6.39) 1.01

Dividend

Metric DERM SIGA Drug Manufacturers Specialty & Generic median
Dividend yield — 0.00% 1.45%
Payout ratio — — 0.27

Size

Metric DERM SIGA Drug Manufacturers Specialty & Generic median
Market cap 121.36m 213.40m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack